About
Technology
Issues
FAQ
Links
Official Page
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.